Fisher & Paykel Healthcare unveils its smallest and lightest mask yet with the F&P Nova Micro™
Weighing less than 40 grams (1.4 ounces), the new compact mask features minimal, easy-adjusting headgear and a soft MicroPillows™ cushion that nestles gently within the nostrils and inflates to conform to the patient’s nose. The design provides stability and freedom of movement, allowing patients to sleep in their preferred position.
“Nova Micro was created for patients wanting a mask that doesn’t compromise on comfort and performance,” said Andrew Somervell, VP Products and Technology. “‘Less is best’ was the mantra for our teams throughout the development process, and the result is our smallest and lightest mask yet.1
“We see this as another strong addition to our mask portfolio. With this new nasal pillows option, along with our recently released F&P Solo AutoFit mask and the F&P Evora Full, we will be able to cater to a wide range of patient needs and preferences,” said Mr Somervell.
Sales of F&P Nova Micro have commenced in New Zealand and will begin in Canada in the coming months. Launches into Australia, Europe and the United States will follow later this calendar year.
The headgear is one size, with three different MicroPillows cushion sizes (small, medium and large).
The mask is supported by positive internal validation trial results:
- 97% of users rated the feel of the F&P Nova Micro mask pillows in their nose as “soft” or “very soft” 2; and
- 100% of users rated the overall performance of the F&P Nova Micro mask as “good” or “very good” 3.
1 F&P Nova Micro is the lightest and volumetrically smallest Fisher & Paykel Healthcare CPAP therapy mask. The considered volume of the mask excludes the tubing. A smaller mask can result in less mask contact on the face, having the potential to reduce unwanted effects such as discomfort, facial irritation, and red marks left on the face.
2 38 out of 39 participants rated the feel of the F&P Nova Micro mask pillows in their nose as “soft” or “very soft”. Internal validation trial conducted by Fisher & Paykel Healthcare on 39 participants in the United States, 2022.
3 39 out of 39 participants rated the overall performance of the F&P Nova Micro mask as “good” or “very good”. Internal validation trial conducted by Fisher & Paykel Healthcare on 39 participants in the United States, 2022.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
|
Authorised by Lewis Gradon, Managing Director and Chief Executive Officer.